Identification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP)
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Healthy Volunteers
Interventions: DRUG: Rosuvastatin|DRUG: Rosuvastatin (Inhibitor arm)|DRUG: Eltrombopag
Sponsor: University of California, San Francisco
Collaborators: Food and Drug Administration (FDA)